Preparation method of vitamin E eye cream
A vitamin and eye cream technology, applied in skin care preparations, medical preparations containing active ingredients, pharmaceutical formulas, etc., can solve the problems of inability to reduce cellular oxygen consumption, inability to apply to various skins, and inability to achieve anti-aging, etc. Achieve novel design, improve skin texture, and use safe effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0055] In the embodiment of the present invention, a preparation method of vitamin E eye cream comprises four phases A, B, C and D, and phase A is deionized water;
[0056] Phase B includes the following components by mass percentage: carbomer 0.1-0.5%, polyol 1-5%, xanthan gum 0.07-0.15%, panthenol 0.1-0.5%, hydroxyethyl urea 3-7%, tobacco Amide 1-4%, Glycerol-26 1-4%, Disodium EDTA 0.01-0.05%, Laminaria palmatum extract 0.1-0.5%, Phenylhydroethanol 0.1-0.5%, Phenyl alcohol 0.06-0.13%, Vitamin E1-5% and humectant 0.7-3%;
[0057] Phase C includes the following ingredients by mass percentage: PEG-100 stearate 1-5%, emulsifier 1-7%, polydimethylsiloxane 0.5-3%, cyclopentasiloxane 0.7-3%, capric triglyceride 2-8%, hydrogenated polydecene 0.5-1.3%, avocado butter 3-8%, oil 0.3-0.8%, polyglycerin-3 0.3-0.8% and synthetic fluorine gold Mica 0.1-0.5%;
[0058] Phase D includes the following components in mass percentage: 3-7% of hemp oil and 3-7% of squalane.
[0059] Further, t...
Embodiment 2
[0078] Prepare according to the mode of embodiment 1, what is different from embodiment 1 is:
[0079] The ingredients of phase B adopt the following mass ratio: carbomer 0.2-0.3%, polyol 2-2.5%, xanthan gum 0.09-0.12%, panthenol 0.3-0.4%, hydroxyethyl urea 4-5%, nicotinamide 2-3%, glycerol polyether-262-3%, disodium EDTA 0.03-0.04%, kelp palmate extract 0.4-0.5%, phenylhydroethanol 0.3-0.5%, phenylethyl alcohol 0.09-0.1%, vitamin E 3 -4% and humectants 0.9-1.5%;
[0080] The components of phase C adopt the following mass ratio: PEG-100 stearate 3-4%, emulsifier 3-5%, polydimethylsiloxane 0.9-1.5%, cyclopentasiloxane 0.9 -1.5%, Capric Triglyceride 4-5%, Hydrogenated Polydecene 0.9-1.1%, Shea Butter 7-8%, Oil 0.6-0.8%, Polyglycerin-3 0.5-0.6% and Synthetic Fluorphlogopite 0.3-0.4%.
[0081] Further, the mass ratio among phase A, phase B, phase C and phase D is: 7-10:4-6:4-5:3-4.
[0082] Experiment 1
[0083] Test population: 60 women aged 30-55;
[0084] Test environment...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap